Nine out of ten patients with prostate cancer treated with radiotherapy robotic Cyberknife maintain their sexual capacity.
Nine out of ten patients with prostate cancer treated with radiotherapy robotic – Cyberknife maintain their sexual capacity. -the biochemical control of the initial prostate cancer patients treated with the Cyberknife system reaches up to 93% in five years Madrid, July of 2012. During the course of robotic Radioterapia Guiada por Imagen in time Real – CyberKnife which was held in the center of formation of the Foundation group IMO on 21 and 22 June in Madrid, Dr. Rafael Garcia, Coordinator of the radiotherapy and robotic radiosurgery center – group CyberKnife IMO has referred to , between 80 and 90% of patients with early stage prostate cancer, treated with this modern technique they maintain full their capacity sexual after receiving treatment and the biochemical control of the disease is 93% at age five by what it can be said that this technique has great advantages compared to conventional radiotherapy or with the own radical Prostate Surgery ”. A comfortable and safe for the patient technique Robotic CyberKnife radiotherapy allows an excellent capacity to monitor the tumor during a submillimetre precision radiation, applying only the tumor a high dose of radiation reflecting a decrease toxicity in bodies so close to the prostate as the bladder and rectum. For Dr. Silvia Sánchez, specialist in radiation oncology radiotherapy and radiosurgery robotic – Grupo IMO CyberKnife Center of is a treatment of precision...
Read More